JIR
TTP

James Investment Research’s TITAN PHARMACEUTICAL INC TTP Stock Holding History

James Investment Research’s Portfolio TTP Stock Details TTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-174,140
Closed -$137K – 557
2014
Q2 		$137K Buy
+174,140
New +$137K ﹤0.01% 331

Other funds holding TTP

GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
VIA
Vantage Investment Advisors State College, Pennsylvania $477M AUM 17.38% 1-Year Est. Return
ECM
Estabrook Capital Management New York $685M AUM 26.64% 1-Year Est. Return

James Investment Research's TTP Position: Q3 2014 in Review

James Investment Research sold out of TITAN PHARMACEUTICAL INC (TTP) in Q3 2014, closing a stake of 174,140 shares — an estimated $137K sold.

James Investment Research first reported a position in TTP in Q2 2014 and held it in 1 quarter. The position peaked at $137K in Q2 2014. 3 funds tracked by Wall St. Rank hold TTP as of Q3 2014.

  • James Investment Research reported no remaining TITAN PHARMACEUTICAL INC position as of Q3 2014 after selling out during the quarter.
  • James Investment Research sold 174,140 TITAN PHARMACEUTICAL INC shares in Q3 2014, an estimated $137K.
  • James Investment Research first reported a position in TITAN PHARMACEUTICAL INC in Q2 2014 and held it in 1 quarter.
  • James Investment Research's TITAN PHARMACEUTICAL INC position peaked at $137K in Q2 2014.
  • 3 funds tracked by Wall St. Rank held TITAN PHARMACEUTICAL INC as of Q3 2014.

Based on James Investment Research's 13F filing for Q3 2014, filed 9 Oct 2014.